Paloma Partners Management CO Nuvasive Inc Transaction History

Paloma Partners Management CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$64.02 - $71.72 $301,470 - $337,729	-4,709 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$53.26 - $68.08 $250,801 - $320,588	4,709 New	4,709 $309,000
Q3 2020 Nov 16, 2020	SELL	$47.43 - $60.75 $766,279 - $981,477	-16,156 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.51 - $66.59 $702,947 - $1.08 Million	16,156 New	16,156 $900,000
Q1 2020 May 15, 2020	SELL	$32.82 - $81.13 $188,813 - $466,740	-5,753 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$60.96 - $77.7 $70,713 - $90,132	1,160 Added 25.26%	5,753 $446,000
Q3 2019 Nov 14, 2019	BUY	$55.78 - $68.08 $256,197 - $312,691	4,593 New	4,593 $291,000
Q2 2018 Aug 14, 2018	SELL	$48.15 - $56.68 $448,661 - $528,144	-9,318 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$46.03 - $61.28 $270,104 - $359,591	5,868 Added 170.09%	9,318 $487,000
Q4 2017 Feb 14, 2018	SELL	$50.58 - $60.79 $917,925 - $1.1 Million	-18,148 Reduced 84.03%	3,450 $202,000
Q3 2017 Nov 14, 2017	BUY	$53.54 - $68.0 $1.16 Million - $1.47 Million	21,598	21,598 $1.2 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.